Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors ; volume:17 ; number:1 ; day:12 ; month:1 ; year:2018 ; pages:1-12 ; date:12.2018
Molecular cancer ; 17, Heft 1 (12.1.2018), 1-12, 12.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Zhang, Erhao
- Beteiligte Personen und Organisationen
-
Gu, Jieyi
Xu, Hanmei
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0759-3
- URN
-
urn:nbn:de:1111-201803163368
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Erhao
- Gu, Jieyi
- Xu, Hanmei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cell therapy for multiple myeloma
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cell therapy for multiple myeloma
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric Antigen Receptor T Cell Research For Clinical Applications